Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Bauersachs

Showing results (21-30 of 132) with videos related to

Pageof 14
Sort By:
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|May 10, 2021
Re "Is Management of Major Bleeding in Patients Taking Anticoagulants Restricted to Reversal Strategies?"Stavros K Kakkos, Manjit Gohel, Rupert Bauersachs
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 7, 2018
Betrixaban for prevention of venous thromboembolism in acute medically ill patientsJan Beyer-Westendorf, Peter Verhamme, Rupert Bauersachs
Thrombosis and Haemostasis|March 30, 2007
The management of thrombosis in pregnancy: role of low-molecular-weight heparinAndré Kher, Rupert Bauersachs, Jorn Dalsgaard Nielsen
Zentralblatt Fur Chirurgie|March 6, 2020
[Modern Finding-Specific and Patient-Adapted Management of Peripheral Pseudoaneurysms after Arterial Access]Max Spazier, Frank Meyer, Rupert Bauersachs, et al.
Journal of the American College of Cardiology|January 22, 2025
Reply: Where the Definition of Fragility Came From and Where It Will GoMario Enrico Canonico, Rupert Bauersachs, Marc P Bonaca
Critical Reviews in Oncology/Hematology|November 19, 2018
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactionsHanno Riess, Paolo Prandoni, Sebastian Harder, et al.
Presse Medicale (Paris, France : 1983)|November 9, 2015
Treatment of pulmonary embolismHervé Décousus, Patrick Mismetti, Francis Couturaud, et al.
Thrombosis and Haemostasis|April 27, 2012
The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER)Heyder Omran, Rupert Bauersachs, Siegfried Rübenacker, et al.
The Patient|July 28, 2016
Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature ReviewThomas Wilke, Sabine Bauer, Sabrina Mueller, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 8, 2008
A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparinFrank Gerdsen, Beate Luxembourg, Florian Langer, et al.
Pageof 14

Showing results (21-30 of 132) with videos related to

Sort By:
Pageof 14
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|May 10, 2021
Re "Is Management of Major Bleeding in Patients Taking Anticoagulants Restricted to Reversal Strategies?"Stavros K Kakkos, Manjit Gohel, Rupert Bauersachs
European Heart Journal Supplements : Journal of the European Society of Cardiology|July 7, 2018
Betrixaban for prevention of venous thromboembolism in acute medically ill patientsJan Beyer-Westendorf, Peter Verhamme, Rupert Bauersachs
Thrombosis and Haemostasis|March 30, 2007
The management of thrombosis in pregnancy: role of low-molecular-weight heparinAndré Kher, Rupert Bauersachs, Jorn Dalsgaard Nielsen
Zentralblatt Fur Chirurgie|March 6, 2020
[Modern Finding-Specific and Patient-Adapted Management of Peripheral Pseudoaneurysms after Arterial Access]Max Spazier, Frank Meyer, Rupert Bauersachs, et al.
Journal of the American College of Cardiology|January 22, 2025
Reply: Where the Definition of Fragility Came From and Where It Will GoMario Enrico Canonico, Rupert Bauersachs, Marc P Bonaca
Critical Reviews in Oncology/Hematology|November 19, 2018
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactionsHanno Riess, Paolo Prandoni, Sebastian Harder, et al.
Presse Medicale (Paris, France : 1983)|November 9, 2015
Treatment of pulmonary embolismHervé Décousus, Patrick Mismetti, Francis Couturaud, et al.
Thrombosis and Haemostasis|April 27, 2012
The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER)Heyder Omran, Rupert Bauersachs, Siegfried Rübenacker, et al.
The Patient|July 28, 2016
Patient Preferences for Oral Anticoagulation Therapy in Atrial Fibrillation: A Systematic Literature ReviewThomas Wilke, Sabine Bauer, Sabrina Mueller, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 8, 2008
A prospective analysis of heparin-platelet factor 4 antibodies in pregnant women treated with the low-molecular-weight heparin, dalteparinFrank Gerdsen, Beate Luxembourg, Florian Langer, et al.
Pageof 14